BioCentury | Apr 15, 2013
Company News

Hyseq Inc., Perkin-Elmer Corp. deal

..."universal" gene assay chip using Hyseq's DNA HyChip technology and Perkin-Elmer's DNA analysis technology. The Hyseq...
...it said would reduce sample preparation time and complexity. Perkin-Elmer will invest $10 million in Hyseq...
...a greater than 5 percent equity interest in Hyseq, depending on the final IPO price. Hyseq...
BioCentury | Apr 15, 2013
Clinical News

Hyseq Inc. regulatory update

...sequencing of DNA by hybridization of oligonucleotide probes. (HYSQ files suit against AFFX, see B6) Hyseq...
BioCentury | May 21, 2012
Strategy

Remembrance: The Titan who changed our lives

...and was ultimately acquired by Eli Lilly and Co. He later served as chairman of Hyseq Pharmaceuticals Inc....
...Pharmaceuticals Inc. I first met George Rathmann when he recruited me to join him at Hyseq...
BioCentury | Jun 18, 2007
Tools & Techniques

Nuvelo's stealth target

...Ever since Nuvelo Inc. was formed through the merger of Hyseq Pharmaceuticals Inc. and Variagenics Inc. in 2003...
...lymphoid cells, the target's function is to activate or co-activate lymphocytes. NTB-A was identified at Hyseq...
BioCentury | Mar 27, 2006
Finance

Ebb & Flow

...for NUVO's first two financings following the creation of the company through the merger of Hyseq...
BioCentury | Sep 6, 2004
Strategy

Back to School 2004: Asset accumulation

...can start with virtually no assets if management knows where it wants to go. When Hyseq...
...Knockout mouse models from Deltagen Cellular assays from Aurora (Vertex) $21.3M (common & warrants) as Hyseq...
...generation and optimization technology from Genetastix $55.7M from Variagenics merger $15M (common & warrants) as Hyseq...
BioCentury | Apr 13, 2004
Company News

Gloucester names Mohr CEO

...and a director. Mohr previously was president and CBO of Variagenics , which merged with Hyseq...
BioCentury | Feb 9, 2004
Strategy

Nuvelo's bargain basement pipeline

...In October 2001, Nuvelo Inc. , then called Hyseq Inc., spun out its original array business...
BioCentury | Oct 2, 2003
Financial News

Nuvelo raises $24.5 million

...occlusion. The compound is partnered with Amgen (AMGN). NUVO was formed by the merger of Hyseq...
BioCentury | Mar 3, 2003
Company News

Nuvelo cardiovascular news

...business, pharmacogenomic technology and molecular diagnostic programs. NUVO, which was formed by the merger of Hyseq Pharmaceuticals Inc....
Items per page:
1 - 10 of 163
BioCentury | Apr 15, 2013
Company News

Hyseq Inc., Perkin-Elmer Corp. deal

..."universal" gene assay chip using Hyseq's DNA HyChip technology and Perkin-Elmer's DNA analysis technology. The Hyseq...
...it said would reduce sample preparation time and complexity. Perkin-Elmer will invest $10 million in Hyseq...
...a greater than 5 percent equity interest in Hyseq, depending on the final IPO price. Hyseq...
BioCentury | Apr 15, 2013
Clinical News

Hyseq Inc. regulatory update

...sequencing of DNA by hybridization of oligonucleotide probes. (HYSQ files suit against AFFX, see B6) Hyseq...
BioCentury | May 21, 2012
Strategy

Remembrance: The Titan who changed our lives

...and was ultimately acquired by Eli Lilly and Co. He later served as chairman of Hyseq Pharmaceuticals Inc....
...Pharmaceuticals Inc. I first met George Rathmann when he recruited me to join him at Hyseq...
BioCentury | Jun 18, 2007
Tools & Techniques

Nuvelo's stealth target

...Ever since Nuvelo Inc. was formed through the merger of Hyseq Pharmaceuticals Inc. and Variagenics Inc. in 2003...
...lymphoid cells, the target's function is to activate or co-activate lymphocytes. NTB-A was identified at Hyseq...
BioCentury | Mar 27, 2006
Finance

Ebb & Flow

...for NUVO's first two financings following the creation of the company through the merger of Hyseq...
BioCentury | Sep 6, 2004
Strategy

Back to School 2004: Asset accumulation

...can start with virtually no assets if management knows where it wants to go. When Hyseq...
...Knockout mouse models from Deltagen Cellular assays from Aurora (Vertex) $21.3M (common & warrants) as Hyseq...
...generation and optimization technology from Genetastix $55.7M from Variagenics merger $15M (common & warrants) as Hyseq...
BioCentury | Apr 13, 2004
Company News

Gloucester names Mohr CEO

...and a director. Mohr previously was president and CBO of Variagenics , which merged with Hyseq...
BioCentury | Feb 9, 2004
Strategy

Nuvelo's bargain basement pipeline

...In October 2001, Nuvelo Inc. , then called Hyseq Inc., spun out its original array business...
BioCentury | Oct 2, 2003
Financial News

Nuvelo raises $24.5 million

...occlusion. The compound is partnered with Amgen (AMGN). NUVO was formed by the merger of Hyseq...
BioCentury | Mar 3, 2003
Company News

Nuvelo cardiovascular news

...business, pharmacogenomic technology and molecular diagnostic programs. NUVO, which was formed by the merger of Hyseq Pharmaceuticals Inc....
Items per page:
1 - 10 of 163